Browse by field and institution
Biotechnology & Life Sciences at University of Florida
Genetics, cell biology, biochemistry, microbiology and pharmaceutical preparations. The 35 Biotechnology & Life Sciences technologies University of Florida markets for licensing, each joined to the patent record diligence turns on: who owns it now, whether it is still in force, and how many years of exclusive term remain.
| Published | Technology | Status | Owner | Expiry |
|---|---|---|---|---|
| 2026-04-28 | AAV capsid variants for gene therapy University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 17.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2043-06-04). |
| 2026-03-24 | Lignin solvation using aqueous biologically compatible buffers University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 16.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-07-22). |
| 2026-01-20 | Compositions and methods relating to insecticides University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 16.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-12-12). |
| 2025-09-16 | Personalized treatment of pancreatic cancer University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 15.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-05-03). |
| 2025-01-14 | Mechanistic bacterial efector to prevent apoptosis of human beta cells University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 15.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-03-06). |
| 2025-01-14 | Materials and methods for modifying Wolbachia and paratransformation of arthropods University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 15.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2042-02-23). |
| 2023-10-10 | AAV delivery of shRNA for treatment of pancreatic cancer University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 13.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-10-31). |
| 2023-03-14 | Composition of lactobacillus and berry extract University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 13.1 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-06-27). |
| 2023-02-28 | Modified bacteria for production of nitroaromatics University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 12.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-05-16). |
| 2022-11-29 | Small angiotensin peptide expression system in mammalian cells University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 4.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2030-05-26). |
| 2022-08-23 | N-arylated analogues and uses thereof University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 11.5 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-12-07). |
| 2022-08-09 | Modified gal-1 proteins and uses thereof University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 12.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-10-10). |
| 2022-03-29 | Drug delivery integrated circuit (IC) and system University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 13.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2039-06-16). |
| 2022-03-08 | Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 12.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-10-24). |
| 2021-09-28 | Analogs of vincamine and uses thereof University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 11.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-02-01). |
| 2021-07-13 | N-antigenic form poliovirus virus-like particles comprising thermostable mutations University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 10.9 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-04-18). |
| 2021-07-06 | Delivery of Nrf2 as therapy for protection against reactive oxygen species University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 8.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-02-19). |
| 2021-06-22 | Car based immunotherapy University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 11.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-01-07). |
| 2021-05-25 | Polyamine sulfonamides and uses thereof University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Torrey Pines Institute for Molecular Studies, not University of Florida. Confirm licensing rights with the assignee of record. | Active termAbout 10.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-11-04). |
| 2021-05-11 | Engineered receptor/ligand system for delivery of therapeutic agents University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 11.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2038-03-07). |
| 2020-12-15 | Synthetic MBNL proteins for treatment of repeat expansion disease University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 11.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2037-06-08). |
| 2020-11-17 | Compositions for the treatment of pancreatic cancer and uses thereof University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 10.6 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-12-31). |
| 2020-10-27 | Dielectric coatings for fixed and removable oral prosthetic restorations University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 10.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-10-28). |
| 2020-10-20 | HDAC inhibitor compounds and methods of treatment University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 9.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-06-14). |
| 2020-10-20 | HDAC inhibitor compounds and methods of treatment University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 9.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-06-14). |
| 2020-05-12 | rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 10.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-06-02). |
| 2019-12-24 | Polymeric particles, method for cytosolic delivery of cargo, methods of making the particles University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | Third partyThe patent's current assignee of record is Vanderbilt University, not University of Florida. Confirm licensing rights with the assignee of record. | Active termAbout 10.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-10-25). |
| 2019-10-08 | Determination of methylation state and chromatin structure of target genetic loci University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 10.0 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-06-05). |
| 2019-09-24 | Allosteric inhibitors of thymidylate synthase University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 7.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2034-03-17). |
| 2019-09-17 | LncRNA serves as a biomarker and therapeutic target University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 9.8 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-04-11). |
| 2018-12-25 | Pluripotent tissue harvester and methods of manufacture thereof University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 8.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2035-02-05). |
| 2018-11-27 | Artificial self-sufficient cytochrome P450s University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 9.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2036-02-18). |
| 2016-10-25 | Lactobacillus supplement for alleviating type 1 diabetes University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 3.7 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2030-02-26). |
| 2016-07-05 | Use of relaxin to restore maternal physiology in pregnancies conceived by assisted reproductive technologies University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 7.3 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2033-10-09). |
| 2011-11-15 | Devices for the detection of the presence and/or activity of proteases in biological samples University of Florida | ActiveIn force: granted, with maintenance fees apparently current (not expired). | InstitutionThe patent's current assignee of record matches the marketing institution (University of Florida). | Active termAbout 3.4 years of exclusive patent term remain as of 2026-06-06 (expected expiration 2029-10-19). |
The Owner column flags when a patent's current assignee of record is not the marketing institution (a "Third party" or "Assigned away" tag means you may not be able to license it from that university). The Expiry column reads how much exclusive patent term remains: an "Expiring soon" or "Expired" tag means little or no exclusivity is left, whatever the listing says. Hover any tag for detail; click any column header to sort.